Adrenomedullin receptor antagonism by calcitonin gene-related peptide(8-37) inhibits carotid artery neointimal hyperplasia after balloon injury
Citation
K. Shimizu et al., Adrenomedullin receptor antagonism by calcitonin gene-related peptide(8-37) inhibits carotid artery neointimal hyperplasia after balloon injury, CIRCUL RES, 85(12), 1999, pp. 1199-1205
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
CIRCULATION RESEARCH
SICI code
0009-7330(199912)85:12<1199:ARABCG>2.0.ZU;2-W
Abstract
Intimal injury by angioplasty results in a series of changes, including smo
oth muscle cell hyperplasia, that lead to vascular restenosis. Adrenomedull
in, a potent vasodilator peptide, has natriuretic effects, and its plasma c
oncentration is elevated in cardiovascular diseases. Adrenomedullin is secr
eted by endothelial and vascular smooth muscle cells, but its role in neoin
timal hyperplasia after balloon injury has not been previously described. W
e investigated the role of endogenous adrenomedullin in neointimal hyperpla
sia using an in vivo rat model of postinjury vascular restenosis. In the in
jured rats, bromodeoxyuridine-labeled nuclei in the media of untreated comm
on carotid arteries were increased 2 days after injury, which were suppress
ed by in vivo treatment with the adrenomedullin receptor antagonist calcito
nin gene-related peptide (CGRP)(8-37). Inhibition of neointimal hyperplasia
by CGRP(8-37) was distinct at 7 and 14 days, whereas CGRP(1-37) had no eff
ect. The expression of adrenomedullin in the media of both untreated and tr
eated common carotid arteries was elevated at 2 days and further enhanced i
n hyperplastic intima of untreated common carotid arteries at 7 days. Our f
indings suggest a novel role for endogenous adrenomedullin in balloon injur
y-induced restenosis and indicate that CGRP(8-37) may be useful for the pre
vention of vascular restenosis.